BrightGene Bio-Medical Technology688166 
$3.24-3.93%24h
-3.93%24h
Global rank6494
Market cap$1.37B
Change 7d-2.95%
YTD Performance-32.43%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of BrightGene Bio-Medical Technology (688166)
As of September 2024, BrightGene Bio-Medical Technology has a market cap of $1.37B. This makes BrightGene Bio-Medical Technology the world's 6494th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of BrightGene Bio-Medical Technology from 2019 to 2024
-
Value:-
Market cap history of BrightGene Bio-Medical Technology from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.47B | -29.54% |
| 2023 | $2.08B | 55.07% |
| 2022 | $1.34B | -38.52% |
| 2021 | $2.19B | -19.85% |
| 2020 | $2.73B | 44.16% |
| 2019 | $1.89B | - |
688166 Market Cap Today is $1.37B -3.93% - 18 Sept 2024
View largest stocks by market cap 
